Synopsis: The use of systemic corticosteroids in early acute respiratory distress syndrome (ARDS) improves measures of lung injury and as well as outcomes in ARDS. Source: Meduri GM, Golden E, Freire AX, et al. Methylprednisolone therapy in early, severe ARDS. Results of a randomized controlled trial. Chest. 2007;131:954–963.